Last reviewed · How we verify

NCT07219004

Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.

Completed NA Last updated 21 October 2025
What this trial tests

NA trial testing amniotic membrane in Lower Extremity Chronic Ulcers in Diabetics in 30 participants. Completed in 27 September 2023.

Timeline
3 March 2023
Primary endpoint
27 September 2023
27 September 2023

Quick facts

Lead sponsorTides Medical
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date3 March 2023
Primary completion27 September 2023
Estimated completion27 September 2023
Sites5 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Tides Medical

Who can join

18 and older, any sex, with Lower Extremity Chronic Ulcers in Diabetics or Diabetic Foot Ulcer (DFU). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is study is to determine if A tri-layered dehydrated human amnion/chorion/amnion composite graft would help non-healing lower extremity diabetic ulcers to heal over a 12 week time period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of amniotic membrane

Trials testing the same drug.

Other Tides Medical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07219004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing